Enlivex Therapeutics Ltd.

• locale

  Israel

• market

  STOCKS

• industry

  Biotechnology

• website

  www.enlivex.com

• ipo date

  Jul 31, 2014

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Z...Show More

*Estimate based on analyst consensus